Short Interest in Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Grows By 181.6%

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) was the target of a large increase in short interest in December. As of December 15th, there was short interest totalling 105,600 shares, an increase of 181.6% from the November 30th total of 37,500 shares. Based on an average daily trading volume, of 133,500 shares, the days-to-cover ratio is currently 0.8 days.

Tevogen Bio Price Performance

TVGNW stock opened at $0.06 on Friday. Tevogen Bio has a one year low of $0.01 and a one year high of $0.28. The company’s fifty day moving average price is $0.06 and its 200-day moving average price is $0.04.

About Tevogen Bio

Tevogen Bio Holdings Inc operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients.